NAD+ injections for brain function: what the evidence actually shows

What's this video probably claiming?

Based on the caption and hashtag context, this creator is likely pitching NAD+ wellness injections or IV infusions as a reliable way to sharpen your thinking, fight fatigue, and accelerate cellular repair. The framing is aspirational: "this is your sign" positions it as an invitation rather than a medical recommendation, which is a common soft-sell tactic in the telehealth wellness space. The claims bundle brain function, mental clarity, focus, energy, and cellular repair into a single product benefit. That's a lot of ground for one molecule to cover. The hashtag #mentalclarity alongside #boost suggests the video is aimed at people who feel foggy or low-energy, not people with diagnosed NAD+ deficiency. This matters because the population being targeted and the population studied in clinical research are almost never the same group.

What does the science actually show?

NAD+ (nicotinamide adenine dinucleotide) is a real coenzyme involved in mitochondrial energy metabolism, DNA repair, and sirtuin activation. None of that is disputed. The problem is the gap between preclinical findings and human clinical outcomes. A 2023 randomized controlled trial by Brakedal et al. in Cell Metabolism tested nicotinamide riboside (an NAD+ precursor) in Parkinson's patients and found it raised blood NAD+ levels by roughly 40-50% but produced only modest, inconsistent neurological improvements. Yoshino et al. (2021, Science) showed NMN supplementation improved muscle insulin sensitivity in postmenopausal women with prediabetes, but cognitive outcomes were not measured. A 2020 review by Lautrup et al. in Cell Metabolism acknowledged that NAD+ depletion is associated with neurodegeneration in animal models, but explicitly noted the translation to human cognitive enhancement remains unproven. IV delivery does raise plasma levels faster than oral routes, but whether that translates to brain penetrance or functional benefit is not established in controlled human trials.

Where does the social media noise diverge from clinical reality?

The biggest divergence is the certainty of the claims versus the actual state of evidence. Words like "boost brain function" and "enhance focus" imply a well-documented, dose-dependent effect. That does not exist in peer-reviewed literature for healthy adults receiving NAD+ infusions. Most human trials have focused on metabolic disease, aging-related conditions, or substance use disorder recovery, not general cognitive performance in otherwise healthy people. A 2022 study by Dolopikou et al. in Nutrients found NR supplementation improved some oxidative stress markers in older adults but reported no significant cognitive gains. The IV format adds another layer of complexity: IV NAD+ protocols are not standardized, infusion rates vary widely across clinics, and adverse effects including nausea, chest tightness, and flushing during infusion are underreported in promotional content. Regulatory agencies including the FDA have not approved NAD+ IV therapy for any cognitive indication.

What should you actually know?

NAD+ is not a scam molecule. The underlying biology is real and research is active. But "active research" and "proven clinical benefit for your brain" are not the same statement, and wellness clinics routinely conflate them. If you are considering NAD+ infusions for cognitive health, ask specifically: what outcome are you measuring, what is the dosing protocol, and what does the clinic do if you have an adverse infusion reaction? Those are reasonable questions that promotional TikTok content will not answer. Oral NAD+ precursors like NMN or NR are significantly cheaper than IV infusions, have a more established safety profile in the literature, and show comparable or better bioavailability data in recent pharmacokinetic studies (Conze et al., 2019, Scientific Reports). Spending several hundred dollars per IV session for an unproven cognitive benefit in a healthy adult is a financial decision, not just a health one.